Suzanne D Turner

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 35

Top Venues

Cancers

Nature communications

British journal of haematology

Leukemia

University of Cambridge

University of Manchester (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Cambridge Oct 01 2017

United Kingdom

Reader :: Pathology

University of Cambridge Oct 01 2014 - Oct 01 2017

United Kingdom

Senior Lecturer :: Department of Pathology

University of Cambridge Jul 01 2012 - Oct 01 2014

United Kingdom

Lecturer :: Department of Pathology

University of Cambridge Jul 01 2005 - Jul 01 2012

United Kingdom

Research Fellow :: Department of Pathology

Babraham Institute Jan 03 2000 - Jul 01 2005

United Kingdom

Research Associate :: Lymphocyte Signalling and Development

AstraZeneca R&D Alderley Park Oct 01 1999 - Dec 31 1999

United Kingdom

Research Associate :: Central Toxicology Labs

Education History

University of Manchester Oct 01 1996 - Oct 01 1999

United Kingdom

PHD :: Paterson Institute for Cancer Research

Publications

Perla Pucci, Liam C Lee, Miaojun Han, Jamie D Matthews, Leila Jahangiri, Michaela Schlederer, Eleanor Manners, Annabel Sorby-Adams, Joshua D Kaggie, Ricky M Trigg, Christopher Steel, Lucy Hare, Emily R James, Nina Prokoph, Stephen P Ducray, Olaf Merkel, Firkret Rifatbegovic, Ji Luo, Sabine Taschner-Mandl, Lukas Kenner, Gladstone A A Burke, Suzanne D Turner
Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma. Nature communications 15 (1) (2024)
Perla Pucci, Liam C Lee, Miaojun Han, Jamie D Matthews, Leila Jahangiri, Michaela Schlederer, Eleanor Manners, Annabel Sorby-Adams, Joshua D Kaggie, Ricky M Trigg, Christopher Steel, Lucy Hare, Emily R James, Nina Prokoph, Stephen P Ducray, Olaf Merkel, Firkret Rifatbegovic, Ji Luo, Sabine Taschner-Mandl, Lukas Kenner, Gladstone A A Burke, Suzanne D Turner
Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma. Nature communications 15 (1) (2024)
Perla Pucci, Liam C Lee, Miaojun Han, Jamie D Matthews, Leila Jahangiri, Michaela Schlederer, Eleanor Manners, Annabel Sorby-Adams, Joshua D Kaggie, Ricky M Trigg, Christopher Steel, Lucy Hare, Emily R James, Nina Prokoph, Stephen P Ducray, Olaf Merkel, Firkret Rifatbegovic, Ji Luo, Sabine Taschner-Mandl, Lukas Kenner, Gladstone A A Burke, Suzanne D Turner
Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma. Nature communications 15 (1) (2024)
Perla Pucci, Liam C Lee, Miaojun Han, Jamie D Matthews, Leila Jahangiri, Michaela Schlederer, Eleanor Manners, Annabel Sorby-Adams, Joshua D Kaggie, Ricky M Trigg, Christopher Steel, Lucy Hare, Emily R James, Nina Prokoph, Stephen P Ducray, Olaf Merkel, Firkret Rifatbegovic, Ji Luo, Sabine Taschner-Mandl, Lukas Kenner, Gladstone A A Burke, Suzanne D Turner
Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma. Nature communications 15 (1) (2024)
Cristina Mastini, Marco Campisi, Enrico Patrucco, Giulia Mura, Antonio P A Ferreira, Carlotta Costa, Chiara Ambrogio, Giulia Germena, Cinzia Martinengo, Silvia Peola, Ines Mota, Elena Vissio, Luca Molinaro, Maddalena Arigoni, Martina Olivero, Raffaele Calogero, Nina Prokoph, Fabrizio Tabbò, Brent Shoji, Laurence Brugieres, Didier Frappaz, Suzanne D Turner, Carlos Cuesta-Mateos, Deborah D'Aliberti, Luca Mologni, Rocco Giovanni Piazza, Carlo Gambacorti-Passerini, Giorgio G Inghirami, Valeria Chiono, Roger Dale Kamm, Emilio Hirsch, Raphael Koch, David M Weinstock, Jon C Aster, Claudia Voena, Roberto Chiarle
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma. Science translational medicine 15 (702) (2023)
Cristina Mastini, Marco Campisi, Enrico Patrucco, Giulia Mura, Antonio P A Ferreira, Carlotta Costa, Chiara Ambrogio, Giulia Germena, Cinzia Martinengo, Silvia Peola, Ines Mota, Elena Vissio, Luca Molinaro, Maddalena Arigoni, Martina Olivero, Raffaele Calogero, Nina Prokoph, Fabrizio Tabbò, Brent Shoji, Laurence Brugieres, Didier Frappaz, Suzanne D Turner, Carlos Cuesta-Mateos, Deborah D'Aliberti, Luca Mologni, Rocco Giovanni Piazza, Carlo Gambacorti-Passerini, Giorgio G Inghirami, Valeria Chiono, Roger Dale Kamm, Emilio Hirsch, Raphael Koch, David M Weinstock, Jon C Aster, Claudia Voena, Roberto Chiarle
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma. Science translational medicine 15 (702) (2023)
Nina Prokoph, Jamie D Matthews, Ricky M Trigg, Ivonne A Montes-Mojarro, Gladstone A A Burke, Falko Fend, Olaf Merkel, Lukas Kenner, Birgit Geoerger, Robert Johnston, Matthew Jonathan Murray, Charlotte Riguad, Laurence Brugières, Suzanne D Turner
Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib. British journal of haematology (2023)
Qian Zhang, Johnvesly Basappa, Hong Y Wang, Selene Nunez-Cruz, Cosimo Lobello, Shengchun Wang, Xiaobin Liu, Seble Chekol, Lili Guo, Amy Ziober, Reza Nejati, Alex Shestov, Michael Feldman, Jerry D Glickson, Suzanne D Turner, Ian A Blair, Chi Van Dang, Mariusz A Wasik
Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function. Leukemia (2023)
Cristina Mastini, Marco Campisi, Enrico Patrucco, Giulia Mura, Antonio P A Ferreira, Carlotta Costa, Chiara Ambrogio, Giulia Germena, Cinzia Martinengo, Silvia Peola, Ines Mota, Elena Vissio, Luca Molinaro, Maddalena Arigoni, Martina Olivero, Raffaele Calogero, Nina Prokoph, Fabrizio Tabbò, Brent Shoji, Laurence Brugieres, Didier Frappaz, Suzanne D Turner, Carlos Cuesta-Mateos, Deborah D'Aliberti, Luca Mologni, Rocco Giovanni Piazza, Carlo Gambacorti-Passerini, Giorgio G Inghirami, Valeria Chiono, Roger Dale Kamm, Emilio Hirsch, Raphael Koch, David M Weinstock, Jon C Aster, Claudia Voena, Roberto Chiarle
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma. Science translational medicine 15 (702) (2023)
Jaques Johan van Heerden, Joyce Balagadde Kambugu, Racheal Angom, Rebecca Claire Lusobya, Guillermo L Chantada, Laurence Desjardins, Ido Didi Fabian, Trijn Israels, Vivian Paintsil, Laila Hessissen, Mame Ndella Diouf, Moatasem Elayadi, Suzanne D Turner, Francine Kouya, Jennifer Ann Geel
Evaluating the baseline survival outcomes of the "six Global Initiative for Childhood Cancer index cancers" in Africa. Pediatric hematology and oncology (2022)
Fabio Santanelli Di Pompeo, Mark W Clemens, Michael Atlan, Giovanni Botti, Peter G Cordeiro, Daphne De Jong, Arianna Di Napoli, Dennis Hammond, Cara L Haymaker, Steven M Horwitz, Kelly Hunt, Peter Lennox, Patrick Mallucci, Roberto N Miranda, Alexandre M Munhoz, Eric Swanson, Suzanne D Turner, Guido Firmani, Michail Sorotos
2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL. Aesthetic surgery journal 42 (11) (2022)
Suzanne D Turner
Commentary on: CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant Associated Anaplastic Large Cell Lymphoma. Aesthetic surgery journal (2022)
Fabio Santanelli Di Pompeo, Mark W Clemens, Michael Atlan, Giovanni Botti, Peter G Cordeiro, Daphne De Jong, Arianna Di Napoli, Dennis Hammond, Cara L Haymaker, Steven M Horwitz, Kelly Hunt, Peter Lennox, Patrick Mallucci, Roberto N Miranda, Alexandre M Munhoz, Demosthenes B Panagiotakos, Eric C Swanson, Suzanne D Turner, Guido Firmani, Michail Sorotos
What is Missing From the Letter to "2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL?" Aesthetic surgery journal (2022)
Lucy Hare, Gladstone A A Burke, Suzanne D Turner
Resistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL. Cancers 13 (23) (2021)
Leila Jahangiri, Tala Ishola, Perla Pucci, Ricky M Trigg, Joao Pereira, John A Williams, Megan L Cavanagh, Georgios V Gkoutos, Loukia G Tsaprouni, Suzanne D Turner
The Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells. Cancers 13 (6) (2021)
L Jeffrey Medeiros, Mario L Marques-Piubelli, Valentina F I Sangiorgio, Roberto Ruiz-Cordero, Francisco Vega, Andrew L Feldman, Jennifer R Chapman, Mark W Clemens, Kelly K Hunt, Mark G Evans, Christine Khoo, Stephen Lade, Mark Silberman, Jerzy Morkowski, Edward M Pina, Daniel C Mills, Christopher M Bates, Winston B Magno, Aliyah R Sohani, Beth A Sieling, Joseph M O'Donoghue, Chris M Bacon, Neill Patani, Despina Televantou, Suzanne D Turner, Laura Johnson, Fiona MacNeill, Andrew C Wotherspoon, Swaminathan P Iyer, Luis E Malpica, Keyur Pravinchandra Patel, Jie Xu, Roberto N Miranda
Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (12) (2021)
Gavin D Garland, Stephen P Ducray, Leila Jahangiri, Perla Pucci, G A Amos Burke, Jack Monahan, Raymond Lai, Olaf Merkel, Ana-Iris Schiefer, Lukas Kenner, Andrew J Bannister, Suzanne D Turner
BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL. Cancers 14 (1) (2021)
Alexander M Newman, Masood Zaka, Peixun Zhou, Alex E Blain, Amy Erhorn, Amy Barnard, Rachel E Crossland, Sarah Wilkinson, Amir Enshaei, Julian De Zordi, Fiona Harding, Mary Taj, Katrina M Wood, Despina Televantou, Suzanne D Turner, Gladstone A A Burke, Christine J Harrison, Simon Bomken, Chris M Bacon, Vikki Rand
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma. Leukemia (2021)
Huan-Chang Liang, Mariantonia Costanza, Nicole Prutsch, Mark W Zimmerman, Elisabeth Gurnhofer, Ivonne-Aidee Montes-Mojarro, Brian J Abraham, Nina Prokoph, Stefan Stoiber, Simone Tangermann, Cosimo Lobello, Jan Oppelt, Ioannis Anagnostopoulos, Thomas Hielscher, Shahid Pervez, Wolfram Klapper, Francesca Zammarchi, Daniel Adriano Silva, K Christopher Garcia, Julien S Baker, Martin Janz, Nikolai Schleussner, Falko Fend, Šárka Pospíšilová, Andrea Janiková, Jacqueline Wallwitz, Dagmar Stoiber, Ingrid Simonitsch-Klupp, Lorenzo Cerroni, Stefano Pileri, Laurence L de Leval, David Sibon, Virginie Fataccioli, Philippe Gaulard, Chalid Assaf, Fabian Knörr, Christine Damm-Welk, Wilhelm Woessmann, Suzanne D Turner, A Thomas Look, Stephan Mathas, Lukas Kenner, Olaf Merkel
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma. Nature communications 12 (1) (2021)
Mary M Taj, Britta Maecker-Kolhoff, Rebecca Ling, Simon Bomken, Birgit Burkhardt, Alan Kwok Shing Chiang, Monika Csoka, Anna Füreder, Stéphanie Haouy, Jelena Lazic, Natalia Miakova, Veronique Minard-Colin, Suzanne D Turner, Anne Uyttebroeck, Andishe Attarbaschi, null null
Primary post-transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients. British journal of haematology 193 (6) (2021)
Leila Jahangiri, Perla Pucci, Tala Ishola, Ricky M Trigg, John A Williams, Joao Pereira, Megan L Cavanagh, Suzanne D Turner, Georgios V Gkoutos, Loukia G Tsaprouni
The Contribution of Autophagy and LncRNAs to MYC-Driven Gene Regulatory Networks in Cancers. International journal of molecular sciences 22 (16) (2021)
Lara Mussolin, Marié-Cecilé Le Deley, Elisa Carraro, Christine Damm-Welk, Andishe Attarbaschi, Denise Williams, Amos Burke, Keizo Horibe, Atsuko Nakazawa, Grazyna Wrobel, Georg Mann, Monika Csóka, Anne Uyttebroeck, Rafael Fernández-Delgado Fernández-Delgado Cerdá, Auke Beishuizen, Karin Mellgren, Birgit Burkhardt, Wolfram Klapper, Suzanne D Turner, Emanuele S G D'Amore, Laurence Lamant, Alfred Reiter, Wilhelm Woessmann, Laurence Brugières, Marta Pillon On Behalf Of The European Inter-Group For Childhood Non-Hodgkin Lymphoma Pillon
Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Long Term Results of the International ALCL99 Trial. Cancers 12 (10) (2020)
Elisabeth S Gruber, Georg Oberhuber, Dietmar Pils, Theresa Stork, Katharina Sinn, Sylvia Gruber, Robert Nica, Dan Kolmer, Suzanne D Turner, Michaela Schlederer, Joachim Widder, Wolfgang Doerr, Béla Teleky, Lukas Kenner
The Determination of Immunomodulation and Its Impact on Survival of Rectal Cancer Patients Depends on the Area Comprising a Tissue Microarray. Cancers 12 (3) (2020)
Cosimo Lobello, Boris Tichy, Vojtech Bystry, Lenka Radova, Daniel Filip, Marek Mraz, Ivonne-Aidee Montes-Mojarro, Nina Prokoph, Hugo Larose, Huan-Chang Liang, Geeta G Sharma, Luca Mologni, David Belada, Katerina Kamaradova, Falko Fend, Carlo B Gambacorti-Passerini, Olaf Merkel, Suzanne D Turner, Andrea Janikova, Sarka Pospisilova
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. Leukemia 35 (5) (2020)
Philip Turton, Dima El-Sharkawi, Iain Lyburn, Bhupinder Sharma, Preethika Mahalingam, Suzanne D Turner, Fiona MacNeill, Laura Johnson, Stephen Hamilton, Cathy Burton, Nigel Mercer
UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma on behalf of the Medicines and Healthcare products Regulatory Agency Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group. British journal of haematology 192 (3) (2020)
Sorcha Forde, Jamie D Matthews, Leila Jahangiri, Liam C Lee, Nina Prokoph, Tim I M Malcolm, Olivier T Giger, Natalie Bell, Helen Blair, Aengus O'Marcaigh, Owen Smith, Lukas Kenner, Simon Bomken, Gladstone A A Burke, Suzanne D Turner
Paediatric Burkitt lymphoma patient-derived xenografts capture disease characteristics over time and are a model for therapy. British journal of haematology 192 (2) (2020)
Stefanie Kreutmair, Cathrin Klingeberg, Teresa Poggio, Geoffroy Andrieux, Alexander Keller, Christoph Cornelius Miething, Marie Follo, Dietmar Pfeifer, Khalid Shoumariyeh, Claudia Lengerke, Irene Gonzalez-Menendez, Falko Fend, Robert Zeiser, Suzanne D Turner, Leticia Quintanilla-Martinez, Melanie Börries, Justus Duyster, Anna L Illert
Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model. Leukemia 34 (12) (2020)
Anand K Deva, Suzanne D Turner, Marshall E Kadin, Mark R Magnusson, Henry Miles Prince, Roberto N Miranda, Giorgio G Inghirami, William P Adams
Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research. Cancers 12 (12) (2020)
Stephen P Ducray, Karthikraj Natarajan, Gavin D Garland, Suzanne D Turner, Gerda Egger
The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis. Cancers 11 (8) (2019)
Hugo Larose, G A Amos Burke, Eric J Lowe, Suzanne D Turner
From bench to bedside: the past, present and future of therapy for systemic paediatric ALCL, ALK. British journal of haematology 185 (6) (2019)
Moinul Haque, Jing Li, Yung-Hsing Huang, Meaad Almowaled, Carter J Barger, Adam R Karpf, Peng Wang, Will Chen, Suzanne D Turner, Raymond Lai
NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma. Cancers 11 (8) (2019)
Ricky M Trigg, Liam C Lee, Nina Prokoph, Leila Jahangiri, C Patrick Reynolds, G A Amos Burke, Nicola A Probst, Miaojun Han, Jamie D Matthews, Hong Kai Lim, Eleanor Manners, Sonia Martínez-González, Joaquin Pastor, Carmen Blanco-Aparicio, Olaf Merkel, Ines Garces de Los Fayos Alonso, Petra Kodajova, Simone Tangermann, Sandra Högler, Ji Luo, Lukas Kenner, Suzanne D Turner
The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status. Nature communications 10 (1) (2019)
Ricky M Trigg, Suzanne D Turner
ALK in Neuroblastoma: Biological and Therapeutic Implications. Cancers 10 (4) (2018)
Nina Prokoph, Hugo Larose, Megan S Lim, G A Amos Burke, Suzanne D Turner
Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond. Cancers 10 (4) (2018)
Ines Garces de Los Fayos Alonso, Huan-Chang Liang, Suzanne D Turner, Sabine Lagger, Olaf Merkel, Lukas Kenner
The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas. Cancers 10 (4) (2018)

Suzanne D Turner.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Suzanne D Turner